Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation
Alex F. Herrera(City of Hope), Francisco M. Marty(Brigham and Women's Hospital), Vincent T. Ho(Dana-Farber Cancer Institute), Karen K. Ballen(University of Virginia Health System), Andrew M. Bellizzi(University of Iowa), Joseph H. Antin(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Jason L. Hornick(Harvard University), Lindsey R. Baden(Brigham and Women's Hospital), Gabriela Soriano(Memorial Sloan Kettering Cancer Center), Corey Cutler(Harvard University)
Cited by 113
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k